For patients with diffuse astrocytomas, lower HLA-E expression still seemed to correlate with better clinical outcomes, but the results were not statistically significant (p = 0.128 for PFS and p = 0.080 for OS, Log-rank test, Fig. 3c and d). This evidence concerns the gene HLA-E and diffuse astrocytoma.